Drug Industry in Developing Countries

One often overlooked drug market is for diseases that are common in developing countries. In these situations the cost of the trials for bringing these drugs to market is more than what could be made off of profits from sales after approval. Victoria Hale from OneWorld Health discusses the issue in this CNN video interview courtesy of YouTube.